Physician profile
John Kenneth Jenkins
$2,901,253.76
in general payments reported to CMS, 2019-2025
5 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $745 · 2023: $2.9M · 2024: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $2.9M · Consulting Fee: $31K · Travel and Lodging: $689 · Food and Beverage: $35.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $2,868,985.15 |
| Consulting Fee | $30,800.00 |
| Travel and Lodging | $688.96 |
| Food and Beverage | $35.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $2,868,985.15 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12,993.44 | 2023 | Spevigo |
| E.R. Squibb & Sons, L.L.C. | $10,530.52 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $8,000.00 | 2023 | Lynparza |
| Alkermes, INC. | $744.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Jenkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.